Thread by @JonahLupton

I have no idea why $DMTK is down 14% today -- makes no sense. There is no news.

Volume is not that heavy and short interest is up to 25% so the bears/shorts are clearly running the show.

$DMTK is still one of my highest conviction stocks for the next 3-5 years. Adoption with dermatologists will be slow, just like it is for most new technologies but eventually $DMTK will be the standard of care. Dermatologists will use the patch before they use the scalpel.

I still believe $DMTK has enormous upside over the next 5+ years.

Don't forget that PLA is just their first product, they have more genomics smart patches coming to market later this year and next year that should be 10x bigger than the PLA product for melanoma detection.

Luminate could be a monster product for $DMTK luminatedna.com

Here's my writeup on $DMTK from late January when the stock was trading in the high $30s jonahlupton.substack.com/p/dmtk-dermtec…

Here's my recent interview with the CEO of $DMTK

I first got into $DMTK in the mid $30s and kept adding all the way into the low $60s.

The stock continued to rally into the $80s and has since pulled back more than 50% and actually dipped below $37 today.

My cost basis is now $45

It sucks to be losing money on $DMTK but this doesn't change my investment thesis for $DMTK over the next 3-5 years.

The only thing that changed is the stock price.

My conviction in $DMTK is still high. I'm focused on what this company can do for early skin cancer detection.

$DMTK sitting on 200d WMA chrt.biz/DMTK/19074p1cl…